Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This is an international multi-center prospective, double randomized, open, controlled phase
III study with a phase II entrance phase to compare the therapeutic efficacy of thalidomide
plus dexamethasone to conventional melphalan plus prednisone in newly diagnosed myeloma
patients.